IDENTIFICATION OF NEW RVX ADDUCT WITH BLOOD PLASMA PROTEINS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH TANDEM MASSSELECTIVE DETECTION IN HIGH RESOLUTION MODE
Present-day ideas about in vitro and in vivo transformation of V-type oraganophosphorus chemical agent are described. In vitro experiments, a new covalent RVX adduct with blood plasma proteins was identified using HPLC with tandem mass-selective detection in high resolution mode. Data were obtained to evaluate albumin input into RVX detoxification process.